Details
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationRanked by rounds participated in, from announcements in Sep 30, 2026 – Oct 29, 2026. Lead counts include only confirmed lead roles.
New companies 17 · Follow-on 0
Stages: Undisclosed 17
Epyr Undisclosed Selected for grant agreement preparationReverion Undisclosed Selected for grant agreement preparationH2SITE Undisclosed Selected for grant agreement preparationNew companies 7 · Follow-on 0
Stages: Undisclosed 7
Riverlane Undisclosed Planned strategic investmentForesight Undisclosed Planned strategic investmentHiverge Undisclosed Planned strategic investmentNew companies 5 · Follow-on 1
Stages: Seed 3, Series A 1, Series B 1, Undisclosed 1
Atlas Bio $10M SeedMachenta $40M Seed22one Undisclosed Reported venture investmentNew companies 4 · Follow-on 0
Stages: Seed 2, Pre-seed 1, Undisclosed 1
Marrow $2M Pre-seedIMMIX $3.5M UndisclosedCleavr €8M SeedNew companies 4 · Follow-on 0
Stages: Undisclosed 2, Pre-seed 1, Seed 1
Emerald £1.4M Grant and venture fundingGo Eve Undisclosed UndisclosedAffinity Labs $2M Pre-seed funding including grantNew companies 4 · Follow-on 0
Stages: Series A 2, Series B 1, Series C+ 1
Nouscom €120M Series DCarbonFarm €7M Series AEdonia €15M Series A financing package including non-dilutive and bank fundingNew companies 4 · Follow-on 0
Stages: Series C+ 2, Series B 1, Undisclosed 1
Microbiotica £36M Series C first closeOMass Therapeutics $310M Series CSalience Labs $125M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Seed 1
Querio Undisclosed Seed financingCoComply £1.9M UndisclosedFruga £1M First external fundingNew companies 2 · Follow-on 1
Stages: Undisclosed 2, Series B 1
22one Undisclosed Reported venture investmentNevis $70M Series BRobCo Undisclosed Primary investment and employee secondary transactionNew companies 2 · Follow-on 1
Stages: Series C+ 2, Series B 1
Nevis $70M Series BPigment $250M Series ELegora $550M Series ENew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
adsilico £10M Series ASilvia Bio £3M SeedMatter Machine £4M Pre-Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 3
Jenz €540K Pre-seedAffinity Labs $2M Pre-seed funding including grantCodeWall $4M Pre-seedNew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Undisclosed 1
Opply $7.5M UndisclosedDuvo $32M Series ASpiko $90M Series BNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
Opply $7.5M UndisclosedCori Clinical $4M SeedNettle $4.8M SeedNew companies 2 · Follow-on 1
Stages: Pre-seed 2, Series C+ 1
Vessla $3.3M Pre-seedSolvera $6.3M Pre-seedMetaview $60M Series CNew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Undisclosed 1
Ambio €5.1M Seed1KOMMA5° ~€70M Equity financingProcuros €20M Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series B 1
Rabot Energy $50M Series BTODAY €2.8M SeedFinches €2M Pre-seedNew companies 3 · Follow-on 0
Stages: Series B 2, Seed 1
Rabot Energy $50M Series BRivercell $25M SeedHadrian $40M Series BNew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Undisclosed 1
HyLight €13M Funding roundSensible Biotechnologies $47M Series ARevnu $3M SeedNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series A 1
Sensible Biotechnologies $47M Series AFoundational £8.2M Pre-seedZenithon AI $10M SeedNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Autofixer €3M Venture debtCoding Giants ≤€6M Venture debt facilityNew companies 2 · Follow-on 0
Stages: Seed 2
Querio Undisclosed Seed financingStride £4.6M Seed fundingNew companies 2 · Follow-on 0
Stages: Pre-seed 1, Undisclosed 1
Cortas €1.5M Pre-seedOnomondo Undisclosed Majority investmentNew companies 2 · Follow-on 0
Stages: Series C+ 1, Undisclosed 1
Impress €40M Venture debtNouscom €120M Series DNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
22one Undisclosed Reported venture investmentLegora $550M Series E“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.